Trastuzumab Recruiting Phase 2 Trials for Invasive Ductal Breast Carcinoma / Inflammatory carcinoma of the breast / HER2 Positive Breast Cancers / Tubular Breast Cancer Stage III / Tubular Breast Cancer Stage II / Malignant Neoplasm of Female Breast / Mucinous Breast Cancer Stage II Treatment
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT02614794 | A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer | |
NCT02682693 | Denosumab as an add-on Neoadjuvant Treatment (GeparX) |